News & Announcements
-
Imaging Biometrics announces commercial distribution partnership with Arterys
Imaging Biometrics®, LLC (IB), a subsidiary of IQ-AI Limited (LON:IQAI) and the recognized leader in quantitative imaging analysis for brain tumor diagnosis and treatment, today announces it has taken its suite of products online via Arterys’s industry-leading medical AI platform. The products include IB Neuro, the premier magnetic resonance (MR) imaging dynamic susceptibility contrast (DSC)…
-
Imaging Biometrics in Collaboration With Three Top Imaging Centers Awarded $2.57 MM NIH Grant
Elm Grove, WI, USA – Imaging BiometricsTM, LLC (IB), a subsidiary of IQ-AI Limited (LON:IQAI), in collaboration with the Barrow Neurological Institute (BNI), the Mayo Clinic (AZ), and the Medical College of Wisconsin (MCW), has received a $2.57 million, five-year grant award from the National Institutes of Health(NIH) – National Cancer Institute (NCI).
-
Study Using Imaging Biometrics’ Brain Tumor Image Analysis Software Wins 2019’s Top Award from the American Journal of Neuroradiology
Imaging Biometrics, LLC, (IB), a wholly-owned subsidiary of IQ-AI and the recognized industry leader in quantitative imaging analysis for brain tumor diagnosis and treatment, is proud to announce its software applications for vascular mapping of tumors were featured in the top-award-winning article in the March 2020 issue of the American Journal of Neuroradiology (AJNR).
-
AI Metrics and Imaging Biometrics Strike Agreement
AI Metrics, LLC (Birmingham, AL), announced today that is has entered into a global distribution agreement with Imaging Biometrics, LLC, a subsidiary of IQ-AI Limited (LON:IQAI). The agreement grants IB non-exclusive global rights to market and distribute AI Metrics’ LSN image analysis product.
-
Imaging Biometrics Partners with AI Metrics
Imaging Biometrics®, LLC (“IB”), a subsidiary of IQ-AI Limited (LON:IQAI), announced today that is has entered into a global distribution agreement with AI Metrics, LLC (Birmingham, AL).